STOCK TITAN

Titan America Financials

TTAM
FY2025 annual
Revenue $1.7B +1.8% YoY
Net Income $185.4M +11.7% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow $134.9M +19.8% YoY
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

Titan America (TTAM) reported $1.7B in revenue for fiscal year 2025, up 1.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TTAM FY2025

Titan America’s core mechanic is self-funded growth: modest sales gains produced more cash than capex needs while leverage stayed light.

Between FY2023 and FY2025, revenue increased only 4.6% while operating cash flow climbed 30.1%, a gap that points to better cash conversion rather than simple volume-driven growth. By FY2025, operating cash flow of $295.4M still turned into $134.9M of free cash after heavier reinvestment, which suggests the business is not having to borrow aggressively just to maintain or expand capacity.

FY2025 looks less like a debt-dependent industrial balance sheet and more like a cash-cushioned posture: cash rose to $211.8M while long-term debt stayed near $55.4M. That shift matters because short-term liquidity also strengthened sharply, so routine obligations appear to be covered by balance-sheet resources rather than by continual refinancing or squeezed working capital.

The drop in return on equity from 22.1% to 17.9% does not signal weaker operations; net income reached a new high as equity expanded faster than profit. Read together with the larger cash balance, that lower percentage return reflects a thicker capital base and a safer funding mix, not a weaker earnings engine.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 43 / 100
Financial Health Score 43/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Titan America's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Titan America, and counted as zero in the overall score.

Growth
39

Titan America's revenue grew a modest 1.8% year-over-year to $1.7B. This slow but positive growth earns a score of 39/100.

Leverage
84

Titan America carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
77

With a current ratio of 3.03, Titan America holds $3.03 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 77/100.

Cash Flow
59

Titan America has a free cash flow margin of 8.1%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
0

Not available for Titan America, and counted as zero in the overall score.

Piotroski F-Score Partial
5/7

Titan America passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.59x

For every $1 of reported earnings, Titan America generates $1.59 in operating cash flow ($295.4M OCF vs $185.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.7B
YoY+1.8%

Titan America generated $1.7B in revenue in fiscal year 2025. This represents an increase of 1.8% from the prior year.

Net Income
$185.4M
YoY+11.7%

Titan America reported $185.4M in net income in fiscal year 2025. This represents an increase of 11.7% from the prior year.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
$134.9M
YoY+19.8%

Titan America generated $134.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 19.8% from the prior year.

Cash & Debt
$211.8M
YoY+1646.5%

Titan America held $211.8M in cash against $55.4M in long-term debt as of fiscal year 2025.

Shares Outstanding
184M

Titan America had 184M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin
11.1%
YoY+1.0pp

Titan America's net profit margin was 11.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.0 percentage points from the prior year.

Return on Equity
17.9%
YoY-4.2pp

Titan America's ROE was 17.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures
$160.5M
YoY+18.6%

Titan America invested $160.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 18.6% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

TTAM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TTAM annual income statement
MetricFY25FY24FY23FY22
Revenue$1.7B+1.8%$1.6B+2.7%$1.6B+16.7%$1.4B
Interest Expense$4.0M+6.5%$3.8M+24.6%$3.0M+49.5%$2.0M
Income Tax$59.4M+3.2%$57.5M+22.1%$47.1M+177.7%$17.0M
Net Income$185.4M+11.7%$166.1M+7.0%$155.2M+147.5%$62.7M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EPS (Diluted).

TTAM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TTAM annual balance sheet
MetricFY25FY24FY23FY22
Total Assets$1.9B+20.9%$1.6B+4.5%$1.5BN/A
Current Assets$610.0M+58.7%$384.3M+3.0%$372.9MN/A
Cash & Equivalents$211.8M+1646.5%$12.1M-45.0%$22.0M-26.2%$29.8M
Inventory$226.4M-0.5%$227.6M+19.8%$190.0MN/A
Goodwill$221.6M0.0%$221.6M0.0%$221.6MN/A
Total Liabilities$859.8M+5.3%$816.2M+4.8%$779.0MN/A
Current Liabilities$201.2M-15.8%$239.0M-51.4%$492.0MN/A
Long-Term Debt$55.4M-1.0%$56.0M+4.1%$53.7MN/A
Total Equity$1.0B+37.9%$750.0M+4.2%$719.8M+21.4%$592.7M
Retained Earnings$777.7M+30.2%$597.3M+15.2%$518.6MN/A

Not reported in any period shown, so not listed: Accounts Receivable.

TTAM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TTAM annual cash flow statement
MetricFY25FY24FY23FY22
Operating Cash Flow$295.4M+19.1%$248.0M+9.2%$227.1M+27.3%$178.4M
Capital Expenditures$160.5M+18.6%$135.4M+15.6%$117.1M-6.6%$125.4M
Free Cash Flow$134.9M+19.8%$112.6M+2.4%$110.0M+107.5%$53.0M
Investing Cash Flow-$152.2M-12.1%-$135.8M-15.4%-$117.7M+7.6%-$127.3M
Financing Cash Flow$56.4M+145.7%-$123.3M-4.7%-$117.8M-443.7%-$21.7M
Dividends Paid$0-100.0%$85.1M+151.8%$33.8M$0

Not reported in any period shown, so not listed: Share Buybacks.

TTAM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TTAM annual financial ratios
MetricFY25FY24FY23FY22
Net Margin11.1%+1.0pp10.2%+0.4pp9.8%+5.2pp4.6%
Return on Equity17.9%-4.2pp22.1%+0.6pp21.6%+11.0pp10.6%
Return on Assets9.8%-0.8pp10.6%+0.2pp10.4%N/A
Current Ratio3.03+1.4x1.61+0.8x0.76N/A
Debt-to-Equity0.050.0x0.070.0x0.07N/A
FCF Margin8.1%+1.2pp6.9%0.0pp6.9%+3.0pp3.9%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Similar Companies

Frequently Asked Questions

What is Titan America's annual revenue?

Titan America (TTAM) reported $1.7B in total revenue for fiscal year 2025. This represents a 1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Titan America's revenue growing?

Titan America (TTAM) revenue grew by 1.8% year-over-year, from $1.6B to $1.7B in fiscal year 2025.

Is Titan America profitable?

Yes, Titan America (TTAM) reported a net income of $185.4M in fiscal year 2025, with a net profit margin of 11.1%.

As of fiscal year 2025, Titan America (TTAM) had $211.8M in cash and equivalents against $55.4M in long-term debt.

Titan America (TTAM) had a net profit margin of 11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Titan America (TTAM) has a return on equity of 17.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Titan America (TTAM) generated $134.9M in free cash flow during fiscal year 2025. This represents a 19.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Titan America (TTAM) generated $295.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Titan America (TTAM) had $1.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Titan America (TTAM) invested $160.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Titan America (TTAM) had 184M shares outstanding as of fiscal year 2025.

Titan America (TTAM) had a current ratio of 3.03 as of fiscal year 2025, which is generally considered healthy.

Titan America (TTAM) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Titan America (TTAM) had a return on assets of 9.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Titan America (TTAM) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Titan America (TTAM) has an earnings quality ratio of 1.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Titan America (TTAM) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top